We propose that the promotion of miR-181 driven by HBx in HCCs could influence the beta-catenin pathway and promote EpCAM expression by suppressing PTEN protein expression, which may have revealed a novel regulatory link between miR-181a and human EpCAM(+) liver cancer stem/progenitor cells. The gene discussed is EPCAM; the disease is liver cancer.